Celera Licenses Protein IP for Lung Cancer Dx

The firm will use Medical Therapies' midkine patent portfolio to develop lung cancer diagnostics.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories